Yuyu Pharma, Inc.

KSE 000220.KS

Yuyu Pharma, Inc. Shareholders' Equity for the year ending December 31, 2023: USD 86.16 M

Yuyu Pharma, Inc. Shareholders' Equity is USD 86.16 M for the year ending December 31, 2023, a -6.64% change year over year. Shareholders' equity are the residual interest in the assets of a company after deducting liabilities, representing the shareholders' ownership claim.

Yuyu Pharma, Inc. Shareholders' Equity for the year ending December 31, 2022 was USD 92.28 M, a -11.28% change year over year.
Yuyu Pharma, Inc. Shareholders' Equity for the year ending December 31, 2021 was USD 104.02 M, a -0.91% change year over year.
Yuyu Pharma, Inc. Shareholders' Equity for the year ending December 31, 2020 was USD 104.98 M, a 37.31% change year over year.
Yuyu Pharma, Inc. Shareholders' Equity for the year ending December 31, 2019 was USD 76.45 M, a -0.32% change year over year.

Key data

Date	Shareholders' Equity	Minority Interest	Total Equity	Total Stockholders Equity and Liabilities

KSE: 000220.KS

Yuyu Pharma, Inc.

CEO	Mr. Wonsang Yu
IPO Date	Jan. 4, 2000
Location	South Korea
Headquarters	Yuyu Building
Employees	253
Sector	Healthcare
Industries Pharmaceuticals Biotechnology Cosmetics Drugstores & Retail Pharmacies Personal Care

Description

Yuyu Pharma, Inc. develops and markets pharmaceutical products. The company offers various prescription drugs, including osteoporosis, brainbone metabolism-hypocalcemia improvement, cerebral and peripheral circulatory disturbance, tromboembolism, respiratory organ, hypertension, pulmonary tuberculosis therapy, arthrifuge, diabetic neuropathy therapy, eczematous dermatitis drugs, and other circulatory system drugs, as well as antibiotics and skeletal muscle relaxants. It also provides non-prescription drugs and health supplements. The company was formerly known as YuYu Inc. and changed its name to Yuyu Pharma, Inc. in May 2008. Yuyu Pharma, Inc. was founded in 1941 and is headquartered in Seoul, South Korea.

Key trends

Past 5 years